Efficacy of deep brain stimulation in our patients with Parkinson's disease;A mély agyi stimuláció hatékonysága Parkinson-kóros betegeink kezelésében

Ideggyogyaszati Szemle

Volumn 66, Issue 3-4, 2013, Pages 115-120

  Tamás, Gertrúd ^a   Takáts, Annamária ^a   Radics, Péfer ^a   Rózsa, Ildikó ^a   Csibri, Éva ^b   Rudas, Gábor ^b   Golopencza, Péter ^b   Entz, László ^c   Fabó, Dániel ^c   Eross, Loránd ^c  

^a SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c Funkcionalis Idegsebeszeti Osztaly es Neuromodulacios Kozpont   (Hungary)

Author keywords

Deep brain stimulation; Efficacy; Parkinson's disease

Indexed keywords

ANTIPARKINSON AGENT;

AKINESIA; ARTICLE; BRAIN DEPTH STIMULATION; CLINICAL ARTICLE; DAILY LIFE ACTIVITY; DISEASE DURATION; DYSKINESIA; HOEHN YAHR SCALE; HUMAN; MOTOR PERFORMANCE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NEUROPSYCHOLOGICAL TEST; PARKINSON DISEASE; POSTOPERATIVE PERIOD; QUALITY OF LIFE; UNIFIED PARKINSON DISEASE RATING SCALE; VERBAL MEMORY;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; ANTIPARKINSON AGENTS; DEEP BRAIN STIMULATION; ELECTRODES, IMPLANTED; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; PSYCHOMOTOR PERFORMANCE; QUALITY OF LIFE; SUBTHALAMIC NUCLEUS; TREATMENT OUTCOME;

EID: 84876726426     PISSN: 00191442     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Deuschl G, Schade-Brittinger C, Krack P, et al. A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med 2006;355:896-908. (Pubitemid 44315982)
2. Weaver FM, Follett K, Stern M, et al. Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. JAMA 2009;301:63-73.
3. Moro E, Lang AE. Criteria for deep-brain stimulation in Parkinson's disease: review and analysis. Expert Rev Neurother 2006;6:1695-705. (Pubitemid 44904014)
4. Benabid AL, Pollak P, Louveau A, Henry S, de Rougemont J. Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson disease. Appl Neurophysiol 1987;50:344-6. (Pubitemid 18043161)
5. Groiss SJ, Wojtecki L, Südmeyer M, Schnitzler A. Deep brain stimulation in Parkinson's disease. Ther Adv Neurol Disord 2009;2:20-8.
6. Moro E, Lozano AM, Pollak P, et al. Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease. Mov Disord 2010;25:578-86.
7. Williams A, Gill S, Varma T, et al. Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trial. Lancet Neurol 2010;9:581-91.
8. Deep-Brain Stimulation for Parkinson's Disease Study Group. Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease. N Engl J Med 2001;345:956-63.
9. Krack P, Pollak P, Limousin P, Benazzouz A, Deuschl G, Benabid AL. From off-period dystonia to peak-dose chorea. The clinical spectrum of varying subthalamic nucleus activity. Brain 1999;122:1133-46. (Pubitemid 29533128)
10. Follett KA, Weaver FM, Stern M, et al. Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease. N Engl J Med 2010;362:2077-91.
11. Krack P, Batir A, Van Blercom N, et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 2003;349:1925-34. (Pubitemid 37409709)
12. Castrioto A, Lozano AM, Poon YY, Lang AE, Fallis M, Moro E. Ten-year outcome of subthalamic stimulation in Parkinson disease: a blinded evaluation. Arch Neurol 2011;68:1550-6.
13. Smeding HM, Speelman JD, Koning-Haanstra M, et al. Neuropsychological effects of bilateral STN stimulation in Parkinson disease: a controlled study. Neurology 2006;66:1830-6. (Pubitemid 44049811)
14. Defer GL, Widner H, Marié RM, Rémy P, Levivier M. Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD). Mov Disord 1999;14:572-84. (Pubitemid 30011449)
15. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967;17:427-42.
16. Schwab R, England A. Projection technique for evaluating surgery in Parkinson's disease. In: Gillingham FJ, Donaldson IML (eds.). Third Symposium on Parkinson's Disease. Edinburgh, Scotland: Livingstone, 1969. p. 152-8.
17. Movement Disorder Society Task Force on Rating Scales for Parkinson's Disease. The Unified Parkinson's Disease Rating Scale (UPDRS): status and recommendations. Mov Disord 2003;18:738-50.
18. Jenkinson C, Fitzpatrick R, Peto V, Greenhall R, Hyman N. The Parkinson's Disease Questionnaire (PDQ-39): development and validation of a Parkinson's disease summary index score. Age Ageing 1997;26:353-7. (Pubitemid 27448379)
19. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-71.
20. Folstein MF, Folstein S, McHugh PR. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
21. Rey A. The clinical examination in psychology. Paris: Press Universitaire de France; 1964. [French]
22. Erzigkeit H. The Syndrome Short-test for the Assessment of Disturbed Concentration and Memory). Vaterstetten: Vless-Verlagsgesellschaft; 1986. [German]
23. Rey A. Psychological examination for traumatic encephalopathy. Archives de Psychologie, 1941;28:286-340. [French]
24. Welsh MC, Huizinga M. Tower of Hanoi disk-transfer task: influences of strategy knowledge and learning on performance. Learning and Individual Differences 2005;15:283-98. (Pubitemid 41700087)
25. Mathuranath PS, Nestor PJ, Berrios GE, Rakowitz W, Hodges JR. A brief cognitive test battery to differentiate Alzheimer's disease and frontotemporal dementia. Neurology 2000;55:1613-20.
26. Kun M, Szegedi M. Intelligence's Measurement. Budapest: Akadémiai Kiadó; 1996. [Hungarian]
27. Wilt K, Daniels C, Reiff J, et al. Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study. Lancet Neurol 2008;7:605-14.
28. Parsons TD, Rogers SA, Braaten AJ, Woods SP, Tröster AI. Cognitive sequelae of subthalamic nucleus deep brain stimulation in Parkinson's disease: a meta-analysis. Lancet Neurol 2006;5:578-88. (Pubitemid 43867425)
29. Kleiner-Fisman G, Herzog J, Fisman DN, et al. Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes. Mov Disord 2006;21:S290-304. (Pubitemid 44028288)